Alzheimer’s

Pharma Sharon Begley

That pathetic Alzheimer’s pipeline? It’s even worse than you think

Pharmalot Ed Silverman

Pharmalittle: Biogen argues investors overreacted; AstraZeneca wins a key immunotherapy approval

Adam's Take Adam Feuerstein

In biotech, it pays to be bullish on Alzheimer’s trials, even when facts stand in the way

Pharmalot Ed Silverman

FDA is offering a new approach for developing Alzheimer’s drugs. What could that mean?

Health Damian Garde

Fans ‘didn’t care if he messed up’: Glen Campbell’s doctor discusses his struggle with Alzheimer’s

Biotech Sharon Begley

In small Alzheimer’s study, hints of modest benefit from unusual drug

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Former compounder told staff to stop ‘fudging’ after meningitis outbreak

Pharmalot Ed Silverman

Lilly cuts 200 R&D jobs, but insists an Alzheimer’s failure is not the cause

Signal Podcast Luke Timmerman and Meg Tirrell

Listen: Episode 19: From poop transplants to pill politics, here’s the year in ‘Signal’

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Handful of doctors responsible for high levels of fentanyl prescriptions

Health Sharon Begley

Dramatic decline in dementia seen among older adults in the US

Health Judith Graham

Loneliness is bad for your health. This new campaign aims to curb isolation

In the Lab Sharon Begley

Their brains had the telltale signs of Alzheimer’s. So why did they still have nimble minds?

Politics Rebecca Robbins

Alzheimer’s is eroding his memory, but not his determination to vote

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Valeant sued by Sprout investors over female libido pill

Business Rebecca Robbins

Watch: Genetic tests promised to help me achieve peak fitness. What I got was a fiasco

Gut Check Sharon Begley

Can curcumin spice treat Alzheimer’s disease?

In the Lab Bryan Marquard — Boston Globe

MIT’s Susan Lindquist, a pioneer in science, dies at 67

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: New bill would create review board for drug prices

Business Damian Garde

A big Alzheimer’s drug trial now wrapping up could offer real hope — or crush it

In the Lab Usha Lee McFarling

Peter Walter just won the Breakthrough Prize. His work? Trying to heal human brains

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: FDA fast tracks Biogen drug for Alzheimer’s

Health Dylan Scott

Gene Wilder died of Alzheimer’s. His family explains why they didn’t disclose his diagnosis

Endnotes Bob Tedeschi

How do you honor a dementia patient’s end-of-life-wishes?

Business Rebecca Robbins

Athletes are keeping their distance from a genetic test for concussion risks

First Opinion Gary W. Small

Stop undertreating Alzheimer’s disease

In the Lab Sharon Begley

Alzheimer’s researchers seethe over years of missteps after latest drug failure

Biotech Damian Garde

Promising Alzheimer’s treatment flops in new trial, crushing hopes

Health Megan Thielking

$75 for reminders to eat: Alzheimer’s patients face flurry of fees while waiting for specialized care